CS logo
small CS logo
Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr

Evanston, Illinois, United States
Cancer treatment center in Evanston, Illinois
2650 Ridge Ave, Evanston, IL 60201

About Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Abbott
2
Hoffmann-La Roche
2
Hoosier Cancer Research Network
1
Novartis
1
Novartis Pharmaceuticals
1
Pfizer
1
PrECOG, LLC.
1
Puma Biotechnology, Inc.
1
Total Rows: 8

Clinical Trials at Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr


During the past decade, Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails202100.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
2001-05-01
Completed
1,000
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
2001-06-01
Completed
941
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
2003-01-01
2007-01-01
Completed
855
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
2003-02-01
Completed
1,168
Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer
2008-09-15
2017-12-20
Completed
177
Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer
2009-01-01
2010-12-01
Terminated
8
A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
2009-06-29
2015-09-09
Completed
921
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
2011-06-25
2016-06-25
Completed
485

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" #1 sponsor was "Abbott" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Hoosier Cancer Research Network" with 1 trials sponsored, "Novartis" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" #1 collaborator was "Bayer" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Thoracic Oncology Group Australasia (TOGA)" with 1 trials as a collaborator and "University of Sydney" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAbbott: 2Abbott: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Hoosier CancerResearch Network: 1Hoosier CancerResearch Network: 1Novartis: 1Novartis: 1Novartis Pharmaceuticals: 1Novartis Pharmaceuticals: 1Pfizer: 1Pfizer: 1PrECOG, LLC.: 1PrECOG, LLC.: 1Puma Biotechnology, Inc.: 1Puma Biotechnology, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsBayer: 2Bayer: 2AstraZeneca: 1AstraZeneca: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Thoracic OncologyGroup Australasia(TOGA): 1Thoracic OncologyGroup Australasia(TOGA): 1University of Sydney: 1University of Sydney: 1

Clinical Trials Conditions at Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr


According to Clinical.Site data, the most researched conditions in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" are "Colonic Neoplasms" (2 trials), "Colorectal Neoplasms" (2 trials), "Rectal Neoplasms" (2 trials), "Breast Cancer" (1 trials) and "Glioblastoma" (1 trials). Many other conditions were trialed in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" in a lesser frequency.

Clinical Trials Intervention Types at Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr


Most popular intervention types in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" are "Drug" (10 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atrasentan" (2 trials), "Bevacizumab" (2 trials), "Pemetrexed" (2 trials), "Vatalanib" (2 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr


The vast majority of trials in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" are 7 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Clinical Trials Status at Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr


Currently, there are NaN active trials in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 8Completed: 8Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1